Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
332.91
+7.33 (2.25%)
Nov 22, 2024, 4:00 PM EST - Market closed

Bio-Rad Laboratories Market Cap

Bio-Rad Laboratories has a market cap or net worth of $9.32 billion as of November 22, 2024. Its market cap has increased by 5.61% in one year.

Market Cap
9.32B
Enterprise Value
9.10B
1-Year Change
5.61%
Ranking
Category
Stock Price
$332.91

Market Cap Chart

Since December 1, 1998, Bio-Rad Laboratories's market cap has increased from $261.00M to $9.32B, an increase of 3,471.04%. That is a compound annual growth rate of 14.75%.

History

DateMarket Cap% Change
Nov 20, 20249.06B-3.70%
Dec 29, 20239.41B-24.96%
Dec 30, 202212.54B-44.52%
Dec 31, 202122.61B29.99%
Dec 31, 202017.39B56.99%
Dec 31, 201911.08B59.20%
Dec 31, 20186.96B-2.05%
Dec 29, 20177.10B31.92%
Dec 30, 20165.38B32.52%
Dec 31, 20154.06B16.39%
Dec 31, 20143.49B-1.57%
Dec 31, 20133.55B19.03%
Dec 31, 20122.98B10.33%
Dec 30, 20112.70B-6.45%
Dec 31, 20102.89B8.90%
Dec 31, 20092.65B28.98%
Dec 31, 20082.06B-26.11%
Dec 31, 20072.78B27.31%
Dec 29, 20062.18B27.59%
Dec 30, 20051.71B15.63%
Dec 31, 20041.48B0.60%
Dec 31, 20031.47B50.86%
Dec 31, 2002975.80M23.39%
Dec 31, 2001790.80M99.29%
Dec 29, 2000396.80M36.17%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Revolution Medicines 9.50B
Henry Schein 9.33B
Penumbra 9.10B
Qiagen 9.07B
Bio-Rad Laboratories 9.05B
Teleflex 8.97B
HealthEquity 8.97B
Intra-Cellular Therapies 8.84B
Market Cap Rankings